Can a remote nurse boost HIV prevention at kenyan pharmacies?

NCT ID NCT07561658

Not yet recruiting Prevention Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether adding a remote nurse via telehealth to pharmacy-based PrEP/PEP services helps more people start and continue HIV prevention. About 1,580 pharmacy clients in Kenya will either get standard pharmacy care or extra telehealth support with SMS reminders. The goal is to see if the telehealth approach increases medication use and is cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telehealth support (remote nurse counseling and SMS) alongside pharmacy-dispensed PrEP/PEP
What this could lead to: If successful, this could show that telehealth support makes HIV prevention medications more accessible and easier to stick with, potentially reducing new HIV infections.
What could go wrong: This is an early-stage implementation study, not a drug trial. Results may vary by pharmacy setting, and the added cost of telehealth may not be sustainable or effective everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

Kenya Medical Research Institute

Kisumu, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.